ORI found that Dr. Sudhakar Yakkanti (Respondent), former staff scientist and Director of the Cell Signaling, Retinal & Tumor Angiogenesis Laboratory, BTNRH, engaged in research misconduct in research supported by PHS funds, specifically, NCI, NIH, NEI, NIH, and NIDDK, NIH.